Measurement of opioid-induced sedation

Pain Management Nursing

Volumn 2, Issue 4, 2001, Pages 132-149

  Young McCaughan, Stacey ^a   Miaskowski, Christine ^b  

^a U S ARMY MEDICAL RESEARCH AND MATERIEL COMMAND   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALFADOLONE; ALFAXALONE; ALFENTANIL; ANALGESIC AGENT; BARBITURIC ACID DERIVATIVE; BENZATROPINE; BENZODIAZEPINE DERIVATIVE; DEXAMPHETAMINE; DEXTROPROPOXYPHENE; FENTANYL; FENTANYL CITRATE; HYDROMORPHONE; METHYLPHENIDATE; MIDAZOLAM; MORPHINE; NARCOTIC ANALGESIC AGENT; OPIATE; PLACEBO; PROPOFOL; SUFENTANIL;

ARTICLE; AUTONOMIC NERVOUS SYSTEM FUNCTION; CLINICAL OBSERVATION; CONTROLLED RELEASE FORMULATION; CONTROLLED STUDY; DRUG EFFECT; DRUG INDUCED DISEASE; ELECTROENCEPHALOGRAM; ELECTROENCEPHALOGRAPHY; EVOKED RESPONSE; HUMAN; IATROGENIC DISEASE; INFORMATION PROCESSING; MEASUREMENT; MEDICAL ASSESSMENT; MEMORY; MOTOR PERFORMANCE; NERVOUS SYSTEM FUNCTION; NEUROPHYSIOLOGY; PAIN; PERCEPTION; PHYSIOLOGY; PSYCHOMOTOR PERFORMANCE; SEDATION; SOMNOLENCE; TREATMENT FAILURE; VISUAL ANALOG SCALE; REVIEW;

ANALGESICS, OPIOID; DISORDERS OF EXCESSIVE SOMNOLENCE; ELECTROENCEPHALOGRAPHY; HUMAN; NERVOUS SYSTEM PHYSIOLOGY; PSYCHOMOTOR PERFORMANCE; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, NON-P.H.S.; SUPPORT, U.S. GOV'T, P.H.S.; TREATMENT FAILURE;

EID: 0035543123     PISSN: 15249042     EISSN: None     Source Type: Journal    
DOI: 10.1053/jpmn.2001.25169     Document Type: Article

References (78)

1. Assessing distress in pediatric intensive care environments: The COMFORT Scale
2. Methods for monitoring the level of sedation
3. Cerebral effects of long-term oral opioids in cancer patients measured by continuous reaction time
4. Reaction time in cancer patients receiving peripherally acting analgesics alone or in combination with opioids
5. P300-response: Possible psychophysiological correlates in delta and theta frequency channels. A review
6. Respiratory sinus arrhythmia: Autonomic origins, physiological mechanisms, and psychophysiological implications
7. Neurologic monitoring
8. Induction of anesthesia with small doses of sufentanil or fentanyl: Dose versus EEG response, speed of onset, and thiopental requirement
9. Methylphenidate associated with narcotics for the treatment of cancer pain
10. The use of methylphenidate in patients with incident cancer pain receiving regular opiates: A preliminary report
11. The cognitive effects of the administration of narcotic analgesics in patients with cancer pain
12. Neuropsychological effects of methylphenidate in patients receiving a continuous infusion of narcotics for cancer pain
13. Validity and reliability of the observer's assessment of alertness/sedation scale: Study with intravenous midazolam
14. Practical issues in the management of cancer pain
15. Power spectral analysis of EEG during sufentanil infusion in humans
16. Alertness, cognition and morphine in patients with advanced cancer
17. Standardization of the visual analogue scale
18. Measurement of heart rate variability
19. Use of continuous bispectral EEG monitoring to assess depth of sedation in ICU patients
20. Respiratory sinus arrhythmia during recovery from isoflurane -nitrous oxide anesthesia
21. Long latency event related potentials in rats: The effects of changes in stimulus parameters and neurochemical lesions
22. Long-latency event-related potentials in rats: Effects of task and stimulus parameters
23. Dextroamphetamine with morphine for the treatment of postoperative pain
24. Kappa-opioids produce significantly greater analgesia in women than in men
25. Benzodiazepine mediated antagonism of opioid analgesia
26. Visual analogue scales: Measurement of subjective phenomena
27. Comparison of the bispectral index (BIS) and measured drug concentrations for the monitoring effects of propofol, midazolam, alfentanil and isoflurane
28. Evoked potential correlates of visual item recognition during memory-scanning tasks
29. The search for hidden structures: In: Time-series analysis: A comprehensive introduction for social scientists
30. Interactive effects of MK-801 and morphine in EEG, EEG power spectra and behaviour in rats: I. morphine tolerance development
31. Controlled release morphine tablets: A double-blind trial in patients with advanced cancer
32. Outcome of chronic opioid therapy for non-cancer pain
33. A comparison of cognitive impairment due to benzodiazepines and to narcotics
34. EEG analysis based time domain properties
35. Cholecystokinin octapeptide alters morphine-induced effects on EEG power spectra both quantitatively and qualitatively
36. Management of cancer pain
37. Narcotics in the 'elderly'
38. Overview of synaptic transmission
39. Behavioral evidence implicating dopamine in sensorimotor arousal and norepinephrine in the sedative effects of antidepressant drugs
40. Measuring human responses using visual analogue scales
41. Orientation and attention
42. Electroencephalogram bispectral analysis predicts the depth of midazolam-induced sedation
43. Differential changes of laser evoked potentials, late auditory evoked potentials and P300 under morphine in chronic pain patients
44. Cognitive performance, mood and experimental pain before and during morphine-induced analgesia in patients with chronic non-malignant pain
45. Event-related potential correlates of interference between cognitive performance and tonic experimental pain
46. Oral transmucosal fentanyl citrate for premedication in adults
47. On the dependence of P300 latency on stimulus evaluation processes
48. Optimal sedation of mechanically ventilated pediatric critical care patients
49. A metric for thought: A comparison of P300 latency and reaction time
50. The P300 event-related potential
51. Randomised trial of oral morphine for chronic non-cancer pain
52. Spectral analysis of blood pressure and heart rate variability in evaluating cardiovascular regulation: A critical appraisal
53. The pathologic physiology of signs and symptoms of coma
54. Variations in respiratory sinus arrhythmia may reflect levels of anaesthesia
55. Elements of EEG signal processing
56. What every neuroanesthesiologist should know about electroencephalograms and computerized monitors
57. A primer for EEG signal processing in anesthesia
58. Spectral edge frequency - A new correlate of anesthetic depth
59. Controlled sedation with alphaxalone-alphadolone
60. Hydromorphone levels and pain control in patients with severe chronic pain
61. The Halstead-Reitan neuropsychological test battery: Theory and clinical interpretation
62. Psychomotor performance of patients with rheumatoid arthritis: Cross-over comparison of dextropropoxyphene, dextropropoxyphene plus amitriptyline, indomethacin, and placebo
63. Electroencephalographic quantification of opioid effect: Comparative pharmacodynamics of fentanyl and sufentanil
64. EEG quantification of narcotic effect: The comparative pharmacodynamics of fentanyl and alfentanil
65. A multicenter study of bispectral electroencephalogram analysis for monitoring anesthetic effect
66. An introduction to bispectral analysis for the electroencephalogram
67. Pain, sedation and reaction time during long-term treatment of cancer patients with oral and epidural opioids
68. Continuous reaction time after single dose, long-term oral and epidural opioid administration
69. Postural stability during long-term treatment of cancer patients with epidural opioids
70. EEGs during high-dose fentanyl-, sufentanil-, or morphine-oxygen anesthesia
71. Opioid rotation for toxicity reduction in terminal cancer patients
72. Assessment of side effects associated with the use of opioid analgesics to manage postoperative pain in children
73. Driving ability in cancer patients receiving long-term morphine analgesia
74. Strategies and techniques for designing nursing tools and procedures
75. Respiratory sinus arrhythmia: A new, objective sedation score
76. Electroencephalographic effects of fentanyl-, sufentanil- and alfentanil anaesthesia in man
77. Definition of and mechanism for opioid-induced sedation
78. A review of the effects of opioids on psychomotor and cognitive functioning in humans